Neuropilin-2 functions as a coinhibitory receptor to regulate antigen-induced inflammation and allograft rejection
Journal of Clinical Investigation · 2025
DOI: 10.1172/jci172218 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Investigation, 2025. Verfasst von Johannes Wedel und 13 weiteren Autor:innen. Beteiligte Einrichtung: Transplant Research Program and. Hauptthemen laut MEDLINE: Neuropilin-2, Graft Rejection, Inflammation, CD4-Positive T-Lymphocytes. Die Arbeit nennt 90 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NIH NIAID, Isabella Julian Forrest Foundation.
Abstract (Originalsprache)
Coinhibitory receptors function as central modulators of the immune response to resolve T effector activation and/or to sustain immune homeostasis. Here, using humanized SCID mice, we found that neuropilin-2 (NRP2) is inducible on late effector and exhausted subsets of human CD4+ T cells and that it is coexpressed with established coinhibitory molecules including PD-1, CTLA4, TIGIT, LAG3, and TIM3. In murine models, we also found that NRP2 is expressed on effector memory CD4+ T cells with an exhausted phenotype and that it functions as a key coinhibitory molecule. Knockout (KO) of NRP2 resulted in hyperactive CD4+ T cell responses and enhanced inflammation in delayed-type hypersensitivity and transplantation models. After cardiac transplantation, allograft rejection and graft failure were accelerated in global as well as CD4+ T cell-specific KO recipients, and enhanced alloimmunity was dependent on NRP2 expression on CD4+ T effectors but not on CD4+Foxp3+ Tregs. Also, KO Tregs were found to be as efficient as WT cells in the suppression of effector responses in vitro and in vivo. These collective findings identify NRP2 as a potentially novel coinhibitory receptor and demonstrate that its expression on CD4+ T effector cells is of great functional importance in immunity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Transplant Research Program and.
- Division of Nephrology, Department of Pediatrics, Boston Children's Hospital, Boston, Massachusetts, USA.
- Department of Pediatrics, Harvard Medical School, Boston, Massachusetts, USA.
- Computational Health Informatics Program, Boston Children's Hospital, Boston, Massachusetts, USA.
- Transplantation Research Center, Renal Division, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.
- Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.
Förderung
- NIAID NIH HHS
- NIH NIAID
- Isabella Julian Forrest Foundation
- Casey Lee Ball Foundation
Zitieren
APA
Wedel, J., Kochupurakkal, N., Kong, S. W., Bose, S., Lee, J. W., Maslyar, M., Alsairafi, B., MacLeod, K., Liu, K., Zhang, H., Komatsu, M., Nakayama, H., Bielenberg, D. R., & Briscoe, D. M. (2025). Neuropilin-2 functions as a coinhibitory receptor to regulate antigen-induced inflammation and allograft rejection. Journal of Clinical Investigation. https://doi.org/10.1172/jci172218
Vancouver
Wedel J, Kochupurakkal N, Kong SW, Bose S, Lee JW, Maslyar M, et al. Neuropilin-2 functions as a coinhibitory receptor to regulate antigen-induced inflammation and allograft rejection. Journal of Clinical Investigation. 2025. doi:10.1172/jci172218
BibTeX
@article{Wedel2025,
author = {Wedel, Johannes and Kochupurakkal, Nora and Kong, Sek Won and Bose, Sayantan and Lee, Ji-Won and Maslyar, Madeline and Alsairafi, Bayan and MacLeod, Kayla and Liu, Kaifeng and Zhang, Hengcheng and Komatsu, Masaki and Nakayama, Hironao and Bielenberg, Diane R and Briscoe, David M},
title = {Neuropilin-2 functions as a coinhibitory receptor to regulate antigen-induced inflammation and allograft rejection},
journal = {Journal of Clinical Investigation},
year = {2025},
doi = {10.1172/jci172218}
}
EUVIMED